Advertisement

Topics

Latest "Cambridge Healthtech Institute" News Stories

10:42 EST 18th January 2019 | BioPortfolio

Here are the most relevant search results for "Cambridge Healthtech Institute" found in our extensive news archives from over 250 global news sources.

More Information about Cambridge Healthtech Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cambridge Healthtech Institute for you to read. Along with our medical data and news we also list Cambridge Healthtech Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cambridge Healthtech Institute Companies for you to search.

Showing "Cambridge Healthtech Institute" News Articles 1–25 of 6,100+

Friday 18th January 2019

Novartis teams up with Oxford University to study AI and complex diseases

Swiss drugmaker Novartis has announced a five-year partnership with the University of Oxford’s Big Data Institute (BDI) to study how artificial intelligence (AI) can provide insights into complex diseases.


Dr. John Mendlein to Transition to an Advisory Role at Moderna and Join Flagship Pioneering as an Executive Partner

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that John Mendlein, Ph.D., President of Corporate and Product Strategy, will be leaving the Company effective February 1, 2019 to join Flagship Pi...

Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings

Companies enter into multi-year strategic collaboration with Celgene receiving exclusive options to license cell therapies that utilize Obsidian’s Destabilizing Domain technology to modulate IL12 and CD40L activity Collaboration represents Obsidian’s first major partnership and further expands Celgene’s capabilities in cellular immunotherapy...


NICE OK for Bravtovi skin cancer drug

The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for some people with melanoma.

Venetoclax gets NICE approval for chronic lymphocytic leukaemia

The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymphocytic leukaemia.

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artificial intelligence to understand complex diseases and improve drug development.

Clinical Trial Launches to Develop Breath Test for Multiple Cancers

Cancer Research UK recruits first patients in trial to improve the early detection and diagnosis of different cancer types. Study will use Owlstone Medical’s Breath Biopsy platform to identify breath biomarkers to detect and differentiate early-stage disease. Study will recruit 1,500 patients at Addenbrooke’s Hospital, Cambridge. Owlstone Medical, a global diagnostics company...

Thursday 17th January 2019

Exposure to chemicals during pregnancy is not associated with an increase in blood pressure

(Barcelona Institute for Global Health (ISGlobal)) New study analyses the health impact of exposure to 21 non-persistent chemicals among pregnant women

New therapeutic avenue in the fight against chronic liver disease

(Ulsan National Institute of Science and Technology(UNIST)) A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer.

UNIST professor honored with '2018 National Top 12 R&D Performance'

(Ulsan National Institute of Science and Technology(UNIST)) Recent work by Professor Eunmi Choi at South Korea's Ulsan National Institute of Science and Technology (UNIST) has been honored with '2018 National Top 12 R&D Performance'.

New DNA sequencer installed at Harry Perkins Institute

The Harry Perkins Institute of Medical Research (HPIMR) has installed an Illumina NovaSeq 6000 DNA sequencer as part of the Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics. The sequencer will be housed at the single-cell sequencing facility being led by Professor Alistair Forrest at the HPIMR, on behalf of a consortium of cancer researchers from across Perth. Las...

Vaccinex Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503

Vaccinex (Nasdaq:VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders, today announces vice president of preclinical research, Elizabeth Evans, Ph.D., provided a podium presentation at the Cambridge ...

ICER’s ‘Unsupported Price Increase’ Report Due This Fall

Report by the Institute for Clinical and Economic Review will seek to inform the public policy debate on price increases...   

Paul Sekhri Joins eGenesis as President & CEO

Biotech company eGenesis has appointed Paul Sekhri to serve as president and CEO, a position he held at his previous company, Lycera. Sekhri’s experience also includes posts at Teva Pharmaceutical Industries (NYSE: TEVA), Cerimon Pharmaceuticals, and Ariad Pharmaceuticals. Sekhri succeeds eGenesis interim CEO Julie Sunderland, who will join the Cambridge, MA, company’s board of directors. [...

Baylor Scott White Research Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryBaylor Scott White Research Institute Baylor, a subsidiary of Baylor Scott White Health is a medical research institute that offers a wide range of prevention therapies and treatments for various diseases and illness. The institute's research areas comprise allergy and immunology, asthma care, cancer care, diabetes, general surgery, heart and vascular health, metabolic disease, gynecology...

Jane Osbourn, VP R&D @MedImmune, joins an expert panel chaired by Professor Patrick Maxwell of Cambridge University on the future of the relationship between the healthcare industry, academic research and the NHS. #CUHPNHS https://twitter.com/sjaccaud/sta

Jane Osbourn, VP R&D @MedImmune, joins an expert panel chaired by Professor Patrick Maxwell of Cambridge University on the future of the relationship between the healthcare industry, academic research and the NHS. #CUHPNHS https://twitter.com/sjaccaud/status/1085956596973342721 …

BlueNalu, A Cellular Aquaculture Company, Announces World-Class Advisory Board

Nine new interdisciplinary members will support efforts to bring clean seafood to the world BlueNalu, a cellular aquaculture company with a mission to create and provide clean seafood to the world, announced today the formation of its world-class, interdisciplinary advisory board, including leaders at the forefront of ocean health, the culinary industr...

Applying Physics to Energy-Efficient Building Design

NewsDeveloping a perfectly energy-efficient building is relatively easy to do—if you don't give the building's occupants any control over their environment.

Scientists Have Identified a Bone Marrow Backup System

NewsNew research has identified the backup for an important biological system - the hematopoietic system, whose adult stem cells constantly replenish the body's blood supply.

Roswell Park Comprehensive Cancer Center Named One of America’s Best Employers for Diversity

Roswell Park Comprehensive Cancer Center has been recognized as one of America’s Best Employers for Diversity 2019. The Buffalo cancer center was ranked 67th among 500 employers and 8th among the 30 employers within the health care sector to be named to the list, which is based on employee surveys. BUFFALO, N.Y. (PRWEB) January 17, 2019 Roswell Park Comprehensive Cancer Center has been recogniz...

Revising the textbook on introns

A research team from Whitehead Institute has uncovered a surprising and previously unrecogniz

University and Community First to Partner in Midwest to Utilize Innovative 3D Additive Manufacturing Technology to Explore Applications in Medical Device Manufacturing

Grand Valley State University and the applied Medical Device Institute awarded half-million-dollar grant from the Grand Rapids SmartZone for two-and-a-half-year investigation into the use of 3D printing for final medical device manufacturing GRAND RAPIDS, Mich. (PRWEB) January 17, 2019 The half-million-dollar grant from the Grand Rapids SmartZone Local Development Finance Authority will fund a tw...

Mobius Institute Exceeds 100 Authorized Training Centers Worldwide

Mobius Institute enters 2019 with over 100 Authorized Training Centers in 55 countries worldwide to deliver accredited ISO 18436 Vibration Analyst and Asset Reliability Professional (ARP) training & certification Mobius Institute, the premier provider of asset reliability improvement and condition monitoring training, certification, and cond...

Report finds NICE unaware of financial interests of patient groups

A report by the London School of Tropical Medicine (LSTM) found that patient organisations consulted by the UK’s National institute...Read More... The post Report finds NICE unaware of financial interests of patient groups appeared first on Pharmaceutical Technology.

California and the Nordics Join Forces to Propel Danish Life Sciences Startups

The Nordic Mentor Network for Entrepreneurship (NOME) joins forces with the California Life Sciences Institute (CLSI) to give Nordic Life Science startups access to potential partners and capital in one of the world’s most innovative regions. The Nordic life sciences ecosystem is further expanding its operations in the U.S. to gain access to potentia...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks